Company Research · Initiating coverage · October 30, 2026. Nasdaq: RGTI. Financial baseline: June 30, 2026. Conditional valuation horizon: October 2027, using annual operating scenarios ending October 2029. All dollar amounts are USD. This is our first Rigetti fundamental model.
Do Rigetti’s 108-qubit system and government funding justify its stock valuation? They strengthen its ability to keep developing quantum hardware, but do not yet establish repeatable commercial earnings. Our analysis connects system sales, customer concentration, restricted research funding and future dilution. We initiate conditional October 2027 values of $0.90 Bear, $4.40 Base and $16.50 Bull. The Base sits well below the October 29 regular-session close of $12.06, even though it assumes a substantial commercial ramp. The central uncertainty is whether better hardware becomes enough accepted, profitable customer business—not simply whether qubit counts rise.
1. A hardware business with two routes to revenue
Rigetti develops superconducting quantum processors, control systems and cloud access. Its on-premises products serve laboratories and quantum-computing centers; Novera lets customers integrate a smaller processor into their own research setup. The company also manufactures chips at Fab-1. These are distinct economic activities: selling equipment can produce a large but uneven payment, while cloud access can produce repeated usage revenue if customers find the machine useful. Rigetti’s September business description outlines those routes; it does not provide a mature subscription-revenue base.
The potential competitive advantage is control over the hardware stack and a modular architecture that can improve one chiplet and reuse it in larger systems. The corresponding cost is that Rigetti must fund fabrication, cryogenic integration, electronics and engineering before volume is established. A vertically integrated laboratory can learn quickly, but it can also carry a large cost base relative to sales. Our investment test is whether repeat orders and paid usage eventually spread that cost across a much larger customer base.
AWS independently confirms that Cepheus-1-108Q became available on Amazon Braket on April 7, 2026. Twelve nine-qubit chiplets make up the processor. Braket offers on-demand tasks and reservations, alongside other hardware choices. Distribution through AWS is useful access to users, not an exclusive channel or proof of high utilization. Customers can compare architectures; Rigetti must win on useful workloads, reliability and total cost, not on the largest headline qubit number.
2. More qubits and better computation are different milestones
| Checkpoint | Verified status | What remains unproven |
|---|---|---|
| 108-qubit cloud system | Available since April 7; launch median two-qubit fidelity 99.1%, roughly 60 ns gates | Scalable, economically useful fault-tolerant computation |
| Higher system fidelity | April roadmap targeted 99.5% median two-qubit fidelity later in 2026 | The reviewed public specification still shows 99.1%; target achievement is not established here |
| Prototype result | Company reported a best two-qubit gate result of 99.9% at 28 ns | Not the median performance of the whole 108-qubit system |
| C-DAC deployment | January order: $8.4m for an on-premises 108-qubit system; H2 2026 deployment planned | Acceptance, revenue recognition and collection are separate checkpoints |
Gate fidelity describes how accurately a quantum operation is performed. A qubit count says how many physical qubits exist; it does not say how many reliable logical qubits a system can support after error correction. Likewise, a fast individual gate does not establish an end-to-end advantage over a classical computer. The distribution of errors, connectivity, readout, calibration and execution overhead matter together. AWS specifically discusses selecting high-fidelity subsets of the processor, which is a useful reminder that the median is not every gate’s performance.
Our comparison is therefore within a consistent test: the same system size, benchmark and operating conditions over time. The August update described an approximately three-year path toward roughly 1,000 qubits, 99.9% two-qubit fidelity and sub-50-nanosecond gates. We treat that as management’s ambition. The valuation should change when reproducible performance and paying demand improve, not simply when a future roadmap is restated.
3. Q2 growth is real; commercial breadth remains narrow
| USD million, except margin | Q2 2026 | H1 2026 |
|---|---|---|
| Revenue | 5.138 | 9.538 |
| Gross profit | 2.188 | 3.566 |
| Gross margin, calculated | 42.6% | 37.4% |
| Operating loss | (28.062) | (54.013) |
| GAAP net loss | (52.606) | (19.497) |
Q2 revenue rose 185.3% from $1.801 million, but the resulting gross profit remained much smaller than $30.250 million of operating expenses. The quarter’s net loss also included a $29.602 million noncash warrant remeasurement expense. Conversely, H1 benefited from a $24.095 million warrant remeasurement gain. Neither mark measures customer cash generation. We therefore anchor the business discussion in gross profit, operating losses and cash use rather than a headline earnings multiple.
The 10-Q concentration note identifies two customers accounting for 64% and 16% of Q2 revenue: 80% combined. Government entities represented 18% of quarterly sales, so it would be wrong to call the quarter predominantly government revenue. A broader buyer category is not the same thing as a diversified customer base. A single delayed installation or acceptance can materially change a small revenue denominator; a high growth rate does not eliminate that vulnerability.
The $8.4 million C-DAC order is a useful price reference for one disclosed configuration, not a universal selling price or recurring annual revenue. It also illustrates why order value, delivery and earnings need separate treatment. We do not mark the planned H2 deployment as completed without subsequent confirmation, nor add the whole order to historical sales. Larger projects could improve scale, but customer-specific engineering and installation costs can limit the margin benefit.
4. Liquidity buys development time, not immunity from dilution
June 30 liquidity was $541.295 million: $27.763 million of cash and equivalents, $365.946 million of short-term investments and $147.586 million of long-term investments. Rigetti reported no debt, although leases, payables and warrant liabilities remain obligations. H1 operating cash flow was negative $31.993 million; cash purchases of equipment were $16.404 million. Our defined free cash flow—operating cash flow less that capex—was negative $48.397 million. Source: balance sheet and cash-flow statement.
Doubling that half-year cash use gives $96.794 million, a historical annualization rather than a runway forecast. Larger systems, fabrication work and deployments can require spending before receipts arrive. Investment maturities also move cash between balance-sheet categories without creating operating profit. Our scenarios consequently use higher forward cash requirements and do not divide the entire liquidity balance by one favorable quarter to promise a fixed number of years of funding.
The share denominator needs the same discipline. The filing reports 333.769 million basic shares on August 3 and 22.945 million potentially dilutive warrants, options and restricted stock units excluded from loss-per-share calculations, plus 1.340 million unvested customer warrants. Exclusion from accounting EPS does not make the economic overhang disappear. The scenario share counts below are prospective assumptions, not reported GAAP diluted shares.
5. The government award is conditional funding with an equity cost
The September 8 Form 8-K specifies up to $100 million of support: $43.9 million available initially, followed by $29.9 million and $26.2 million subject to milestone approval. Funds are limited to eligible project costs; failures can trigger recovery. The company agreed to issue 7,739,938 shares at an implied $12.92 each. The performance period can extend up to five years. This is not $100 million of unconditional, unrestricted cash or equipment-sale revenue.
The three funded research projects address readout electronics, cryogenic capacity and high-connectivity fabrication. They could remove scaling bottlenecks, but the commercial return still depends on implementation and demand. Our model includes the government shares pro forma while conservatively excluding all award receipts from free liquidity. That prevents unsupported double counting of restricted funds as shareholder cash. We would model actual eligible costs and disbursements together after confirmation; excluding receipts here is a valuation assumption, not a claim that no money has been received.
Using the August share count plus the agreed government issuance gives 341.509 million pro-forma basic shares, before other subsequent changes. At the October 29 regular-session close of $12.06, that implies approximately $4.119 billion of equity value. The quote provider displays $4.03 billion using 333.77 million shares, apparently a lagging denominator. Neither is a fully diluted live market capitalization. Both place this candidate below our historical $10 billion size reference; the pro-forma bridge is the more relevant starting point for dilution analysis.
6. A conditional operating model, not a near-term P/E
Valuation date: October 30, 2026. Target date: October 30, 2027. We use a forward enterprise-value-to-sales framework with explicit funding deductions because current earnings cannot support a meaningful price/earnings ratio. The operating scale below is for the twelve months ending October 2029—not reported results, company guidance, contracted backlog or a promised fiscal-year forecast. System-equivalent units aggregate different configurations; the disclosed C-DAC order informs the price scale, not future volume.
| AHNIM assumption | Bear | Base | Bull |
|---|---|---|---|
| 2029 system-equivalent units | 5 | 20 | 40 |
| Average revenue per unit, $m | 6 | 8 | 10 |
| Cloud, service and other revenue, $m | 10 | 30 | 100 |
| Total annual revenue, $m | 40 | 190 | 500 |
| Terminal EV / annual sales | 6× | 12× | 18× |
| Annual risk discount | 30% | 25% | 20% |
| Annualized cash use, July 2026–October 2027, $m | 140 | 170 | 220 |
| Projected October 2027 liquidity, $m | 354.628 | 314.628 | 247.962 |
| FCF: year ending October 2028, $m | (120) | (100) | (80) |
| FCF: year ending October 2029, $m | (120) | (70) | 20 |
| Prospective diluted shares, million | 370 | 375 | 390 |
| Calculated October 2027 value | $0.9009 | $4.3974 | $16.5261 |
| Published conditional target | $0.90 | $4.40 | $16.50 |
The Bear assumes few repeat deployments and continued cash consumption. The Base requires a genuine product business: roughly twenty system equivalents per year, plus service/cloud demand, with cash losses shrinking as revenue scales. The Bull requires substantially wider adoption and a path to positive cash generation, but also more upfront investment and dilution. None of these unit counts is verified demand. We use them to make the commercial burden of the valuation visible rather than conceal it inside an arbitrary target.
The multiples are our speculative scenario judgments, not an observed peer median. Even 12× sales is generous: at a hypothetical mature 20% operating margin it corresponds to 60× operating profit before tax and reinvestment. The Bull’s 18× requires a particularly durable platform and continued growth beyond 2029. The 30%/25%/20% discount rates express differing execution risk; they are not measured probabilities of success. Failure, recapitalization or technological displacement could produce outcomes below the Bear.
Formula, in millions: October 2027 equity value = projected October 2027 liquidity + FCF₍2028₎/(1+r) + [2029 revenue × terminal EV/sales + FCF₍2029₎]/(1+r)². Divide by prospective diluted shares. Projected liquidity starts at June 30’s $541.295 million and deducts sixteen months of assumed cash use. The Base is [314.6283 − 100/1.25 + (190 × 12 − 70)/1.25²] / 375 = $4.3974. This funding bridge explicitly includes losses after the target date; we do not retain cash that the operating ramp consumes.
Adding the August basic shares, government issuance and disclosed potential securities gives a reference overhang bridge of approximately 365.794 million shares. Our 370–390 million assumptions add room for future awards or other issuance; they are not a prediction that every option or warrant will exercise. We assign no exercise proceeds, conservatively avoiding cash from uncertain transactions. No new borrowing or capital raise is assumed to rescue the model. If funding needs exceed available resources, both the cash bridge and the share denominator must be rebuilt.
7. Sensitivity and the market’s implied hurdle
Holding all other Base inputs constant, changing 2029 revenue by ±25% produces values of $3.42–$5.37. An 8×–16× terminal sales multiple gives $3.10–$5.69. A 10% larger share denominator lowers the Base to about $4.00. Simply adding the entire $100 million award without any associated cost or restriction would add only $0.27 per Base share; that is an illustrative upper-bound arithmetic exercise, not our accounting treatment.
Under the same Base multiple, discount, cash and share assumptions, supporting $12.06 would require approximately $564 million of 2029 annual revenue; supporting $28.53 would require approximately $1.368 billion. These are reverse-solved valuation hurdles, not forecasts. At that scale, costs and investment would probably also change, so they are not substitutes for a complete larger-business model. The calculation shows why a government award or one successful system delivery cannot, by itself, close the valuation gap.
8. Analyst comparison: a large, explicitly dated divergence
StockAnalysis, citing S&P Global displays a rolling one-year mean target of $28.53 across 13 analysts, median $30 and range $17.30–$40. Its target snapshot is dated September 21, 2026, retrieved October 30. Our published Base is 84.6% below that mean: |4.40 − 28.53| / 28.53. Bear and Bull are respectively 96.8% and 42.2% below. These are broadly one-year comparisons, not perfectly synchronized target dates: the broker snapshot predates this model by about five weeks and individual horizons may differ.
This exceeds our 20% review threshold by a wide margin. We rechecked revenue units, terminal multiples, intervening cash use, liquidity restrictions and dilution. The difference primarily reflects how much future commercial scale is credited today, plus our explicit financing deductions. We do not know every broker’s proprietary assumptions and cannot attribute the entire gap to one shared broker forecast. A higher target would require evidence of repeat accepted systems, materially stronger recurring demand and better cash economics—not a decision to match consensus.
The dated rating history shows Jefferies reduced its target from $20 to $18 on August 7 while retaining Hold. The Fly’s report via TipRanks says near-term fidelity execution remained a concern despite a constructive longer-term view. We accessed that reporting, not the original broker note. B. Riley’s September 21 Buy/$35 entry is a reiteration, not a new increase. These actions predate this review and must not be presented as reactions to it.
9. What would change our view?
We would raise the operating scenario after verified fidelity improvements at commercially relevant scale, completed customer acceptance, repeat orders with disclosed economics, and paid usage that grows without disproportionate investment. We would lower it after schedule slippage, concentration-driven revenue reversals, deteriorating system margins or financing needs beyond the current bridge. Government milestone payments should be reconciled to project spending and restrictions before they change our available-cash estimate.
The next scheduled financial checkpoint is Q3 results on November 10, 2026, after the US market close. That release has not occurred as of this review. It should clarify cash, share counts and delivery progress; it may not resolve the longer commercialization question. Competition, calibration instability, manufacturing yield, export or government-funding constraints, and dependence on a small set of buyers remain material risks. A funding cushion reduces immediate financing pressure but does not validate the terminal sales multiple.
Related coverage and research record
Our SkyWater analysis of quantum manufacturing within IonQ examines the different economics of a foundry supplying quantum developers. It is related industry context, not evidence of a Rigetti–SkyWater supply relationship. Our research, AI-use and corrections policy explains editorial responsibility and valuation comparisons.
Initial coverage record: October 30, 2026. No prior AHNIM RGTI target is overwritten. Future revisions should preserve this model and show changed inputs and evidence. This article is informational and educational, not personalized investment advice or a performance guarantee. The cover is an AI-generated editorial illustration of quantum-computing equipment, not a photograph of a Rigetti facility.
Sources and original documents
Rigetti — Form 10-Q, quarter ended June 30, 2026; filed August 6. Statements, concentration and equity notes: https://investors.rigetti.com/node/11311/html
Rigetti — Q2 2026 earnings release, August 6, 2026. Consolidated financials and management roadmap: https://www.sec.gov/Archives/edgar/data/1838359/000110465926091979/rgti-20260806xex99d1.htm
Rigetti — Form 8-K filed September 8, 2026; September 4 award and September 8 securities agreement: https://www.sec.gov/Archives/edgar/data/1838359/000110465926105662/tm2624940d1_8k.htm
Rigetti — definitive government agreement announcement, September 8, 2026; R&D projects and business description: https://investors.rigetti.com/news-releases/news-release-details/rigetti-signs-definitive-agreement-100m-us-government-accelerate
AWS — Cepheus-1-108Q availability and architecture, June 1, 2026; April 7 deployment: https://aws.amazon.com/blogs/quantum-computing/amazon-braket-launches-rigetti-cepheus-1-108q-superconducting-device/
Rigetti — 108-qubit general availability, April 7, 2026; system, prototype and roadmap distinctions: https://investors.rigetti.com/news-releases/news-release-details/rigetti-announces-general-availability-108-qubit-system
Rigetti — public system specifications, reviewed October 30, 2026; not a timestamped live calibration feed: https://www.rigetti.com/what-we-build
Rigetti — January 20, 2026 C-DAC purchase-order announcement, SEC exhibit: https://www.sec.gov/Archives/edgar/data/1838359/000110465926004828/tm263499d1_ex99-1.htm
StockAnalysis — October 29, 2026, 4:00 p.m. EDT regular-session quote; retrieved October 30: https://stockanalysis.com/stocks/rgti/
StockAnalysis / S&P Global — 13-analyst rolling one-year target summary, updated September 21, 2026; retrieved October 30: https://stockanalysis.com/stocks/rgti/forecast/
StockAnalysis / TipRanks — dated analyst-action history, retrieved October 30, 2026: https://stockanalysis.com/stocks/rgti/ratings/
The Fly via TipRanks — Jefferies $20 to $18 reduction; August 7, 2026 action cross-checked against dated history: https://www.tipranks.com/news/the-fly/rigetti-computing-price-target-lowered-to-18-from-20-at-jefferies-thefly-news
Rigetti — October 27, 2026 notice of November 10 Q3 results; future event, not released results: https://investors.rigetti.com/news-releases/news-release-details/rigetti-computing-report-third-quarter-2026-financial-results
Reviewed October 30, 2026 KST. Historical figures retain their stated periods. Financial-statement thousands are converted to millions where labeled. The tables, cash bridge and reverse-valuation calculations are reproducible in our verification record.
Leave a Reply